Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations-Reference-Cited by-同舟云学术

Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations

Published:2018-01-08 Issue:3 Volume:81 Page:483-495
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Rivera-Del Valle Nilsa,Cheng Tiewei,Irwin Mary E.,Donnella Hayley,Singh Melissa M.,Chandra Joya

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3509-0/fulltext.html

Reference34 articles.

1. West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest124(1):30–39

2. Masetti R et al (2011) The role of HDACs inhibitors in childhood and adolescence acute leukemias. J Biomed Biotechnol2011:148046

3. Dasmahapatra G et al (2010) The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo. Blood. 115(22): 4478–4487

4. Mann BS et al (2007) FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist12(10):1247–1252

5. Ryan QC et al (2005) Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol23(17):3912–3922

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring Changes in Intracellular Reactive Oxygen Species Levels in Response to Histone Deacetylase Inhibitors;Methods in Molecular Biology;2022-10-19

2. Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment;Journal of Ethnopharmacology;2022-10

3. Valproic Acid Inhibits Glioma and Its Mechanisms;Journal of Healthcare Engineering;2022-02-10

4. ROS Modulatory Role of HDAC Inhibitors in Cancer Cells;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022

5. ROS Modulatory Role of HDAC Inhibitors in Cancer Cells;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022